ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS
<p>Data of evidence based medicine which confirm efficacy of acetylsalicylic acid (ACA) in cardiologic practice are presented. The special attention is given to generic drugs of ACA. Their application has increased essentially recently. Some of generics are comparable with original drugs on cl...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2016-01-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | http://www.rpcardio.ru/jour/article/view/738 |
_version_ | 1797715523278995456 |
---|---|
author | N. A. Dmitrieva S. N. Tolpygina |
author_facet | N. A. Dmitrieva S. N. Tolpygina |
author_sort | N. A. Dmitrieva |
collection | DOAJ |
description | <p>Data of evidence based medicine which confirm efficacy of acetylsalicylic acid (ACA) in cardiologic practice are presented. The special attention is given to generic drugs of ACA. Their application has increased essentially recently. Some of generics are comparable with original drugs on clinical efficacy but have economic advantages.</p> |
first_indexed | 2024-03-12T08:08:00Z |
format | Article |
id | doaj.art-92e3ee87090049808ca28e93292736ec |
institution | Directory Open Access Journal |
issn | 1819-6446 2225-3653 |
language | English |
last_indexed | 2024-03-12T08:08:00Z |
publishDate | 2016-01-01 |
publisher | Столичная издательская компания |
record_format | Article |
series | Рациональная фармакотерапия в кардиологии |
spelling | doaj.art-92e3ee87090049808ca28e93292736ec2023-09-02T19:20:33ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532016-01-0156555810.1234/1819-6446-2009-6-55-58737ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONSN. A. Dmitrieva0S. N. Tolpygina1Государственный научно-исследовательский центр профилактической медицины РосмедтехнологийГосударственный научно-исследовательский центр профилактической медицины Росмедтехнологий<p>Data of evidence based medicine which confirm efficacy of acetylsalicylic acid (ACA) in cardiologic practice are presented. The special attention is given to generic drugs of ACA. Their application has increased essentially recently. Some of generics are comparable with original drugs on clinical efficacy but have economic advantages.</p>http://www.rpcardio.ru/jour/article/view/738антиагрегантыацетилсалициловая кислотадженерический препарат |
spellingShingle | N. A. Dmitrieva S. N. Tolpygina ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS Рациональная фармакотерапия в кардиологии антиагреганты ацетилсалициловая кислота дженерический препарат |
title | ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS |
title_full | ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS |
title_fullStr | ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS |
title_full_unstemmed | ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS |
title_short | ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS |
title_sort | acetylsalicylic acid in low doses for secondary prevention of cardio vascular complications |
topic | антиагреганты ацетилсалициловая кислота дженерический препарат |
url | http://www.rpcardio.ru/jour/article/view/738 |
work_keys_str_mv | AT nadmitrieva acetylsalicylicacidinlowdosesforsecondarypreventionofcardiovascularcomplications AT sntolpygina acetylsalicylicacidinlowdosesforsecondarypreventionofcardiovascularcomplications |